IQVIA (IQV) stock, ICON (ICLR) stock, and Fortrea (FTRE) stock were downgraded at Barclays, citing impact from potential pharma tariffs. Read more here.

Barclays analyst Luke Sergott upgraded Danaher (DHR – Research Report) to a Buy today and set a price target of $205.00. The company’s shares ...

RBC Capital analyst Conor McNamara maintained a Buy rating on Danaher (DHR – Research Report) on April 1 and set a price target of $270.00. The ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim ...

Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Multi-Factor Investor model based on the published strategy of ...

In its fourth quarter 2024 investor letter, Meridian Hedged Equity Fund emphasized stocks such as Danaher Corporation (NYSE:DHR). Danaher Corporation (NYSE:DHR) manufactures and distributes a ...

Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Multi-Factor Investor model based on the published strategy of ...